[go: up one dir, main page]

AU2001251582A1 - Method and compositions for ordering restriction fragments - Google Patents

Method and compositions for ordering restriction fragments

Info

Publication number
AU2001251582A1
AU2001251582A1 AU2001251582A AU5158201A AU2001251582A1 AU 2001251582 A1 AU2001251582 A1 AU 2001251582A1 AU 2001251582 A AU2001251582 A AU 2001251582A AU 5158201 A AU5158201 A AU 5158201A AU 2001251582 A1 AU2001251582 A1 AU 2001251582A1
Authority
AU
Australia
Prior art keywords
compositions
restriction fragments
ordering restriction
ordering
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251582A
Inventor
Stephen C. Macevicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lynx Therapeutics Inc
Original Assignee
Lynx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/549,748 external-priority patent/US6720179B1/en
Application filed by Lynx Therapeutics Inc filed Critical Lynx Therapeutics Inc
Publication of AU2001251582A1 publication Critical patent/AU2001251582A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001251582A 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments Abandoned AU2001251582A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/549,748 US6720179B1 (en) 1998-02-23 2000-04-14 Method and compositions for ordering restriction fragments
US09549748 2000-04-14
PCT/US2001/011981 WO2001079553A1 (en) 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments

Publications (1)

Publication Number Publication Date
AU2001251582A1 true AU2001251582A1 (en) 2001-10-30

Family

ID=24194242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251582A Abandoned AU2001251582A1 (en) 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments

Country Status (2)

Country Link
AU (1) AU2001251582A1 (en)
WO (1) WO2001079553A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145553B4 (en) * 2001-09-16 2006-06-08 Gene Architects Ag Nucleic acid for a cloning vector
WO2005042781A2 (en) 2003-10-31 2005-05-12 Agencourt Personal Genomics Corporation Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
GB0514935D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Methods for sequencing a polynucleotide template
GB0514910D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Method for sequencing a polynucleotide template
DE602007009634D1 (en) * 2006-01-04 2010-11-18 Si Lok PROCESS FOR THE ALLOCATION OF NUCLEIC ACIDS AND FOR THE IDENTIFICATION OF FINE-STRUCTURED VARIATIONS IN NUCLEIC ACIDS AND AID THEREFOR
WO2007091077A1 (en) 2006-02-08 2007-08-16 Solexa Limited Method for sequencing a polynucleotide template
US7754429B2 (en) 2006-10-06 2010-07-13 Illumina Cambridge Limited Method for pair-wise sequencing a plurity of target polynucleotides
WO2012044847A1 (en) 2010-10-01 2012-04-05 Life Technologies Corporation Nucleic acid adaptors and uses thereof
US8530197B2 (en) 2008-01-09 2013-09-10 Applied Biosystems, Llc Method of making a paired tag library for nucleic acid sequencing
US12060554B2 (en) 2008-03-10 2024-08-13 Illumina, Inc. Method for selecting and amplifying polynucleotides
CA2770389C (en) 2009-08-25 2015-12-29 Illumina, Inc. Methods for selecting and amplifying polynucleotides
KR20220151101A (en) 2020-03-09 2022-11-14 일루미나, 인코포레이티드 Methods of sequencing polynucleotides
US20240279733A1 (en) 2021-12-17 2024-08-22 Illumina, Inc. Orthogonal hybridization
AU2023233839A1 (en) 2022-03-15 2024-01-18 Illumina, Inc. Concurrent sequencing of forward and reverse complement strands on concatenated polynucleotides for methylation detection
WO2023175013A1 (en) 2022-03-15 2023-09-21 Illumina, Inc. Methods for preparing signals for concurrent sequencing
WO2025062002A1 (en) 2023-09-20 2025-03-27 Illumina, Inc. Concurrent sequencing using nick translation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118534T3 (en) * 1993-10-28 1998-09-16 Life Technologies Inc NUCLEIC ACID MARKER STAIRCASE FOR ESTIMATION OF MASS.
US5846719A (en) * 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
US5804382A (en) * 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6054276A (en) * 1998-02-23 2000-04-25 Macevicz; Stephen C. DNA restriction site mapping

Also Published As

Publication number Publication date
WO2001079553A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002361623A1 (en) Methods and compositions for chromatography
EP1341864A4 (en) Method for making abrasive compositions and products thereof
AU2002346651A1 (en) Endorepellin compositions and methods for inhibiting angiogenesis
AU2001251582A1 (en) Method and compositions for ordering restriction fragments
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002357748A1 (en) Osteopontin-related compositions and methods
EP1469769A4 (en) Novel compositions and methods for cancer
AU2002315066A1 (en) Methods for making antibody fragments and compositions resulting therefrom
IL158764A0 (en) Methods and compositions for making emamectin
AU2001233932A1 (en) Method and composition
AU2001283226A1 (en) Methods and compositions for inhibiting rad51
AU2001288736A1 (en) Method and composition for enhancing vision
AU2002337943A1 (en) Novel compositions and methods for cancer
EP1469870A4 (en) Novel compositions and methods for cancer
AU2002239775A1 (en) Chemical-library composition and method
AU2001249194A1 (en) Immunokine composition and method
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2002246221A1 (en) Method and composition
AU2002360454A1 (en) Methods and compositions for treating cancer
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002345932A1 (en) Compositions and methods for treating atherosclerosis
AU2002349439A1 (en) Compositions for eliminating endotoxin and elimination method